United States Onychomycosis Treatment Market Size and Demand 2025-2033
United States Onychomycosis Treatment Market Overview
Base Year: 2024
Historical Years: 2019–2024
Forecast Years: 2025–2033
Market Growth Rate: 5.11% (2025–2033)
The United States onychomycosis treatment market is growing due to the rising prevalence of fungal nail infections, increasing awareness about nail health, and the availability of advanced treatment options. According to the latest report by IMARC Group, United States onychomycosis treatment market size reached USD 552 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 865.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.11% during 2025-2033.
United States Onychomycosis Treatment Industry Trends and Drivers:
The United States onychomycosis treatment market is expanding quickly. This growth comes from a rise in fungal nail infections and increased awareness of treatment options. An aging population, diabetes, and immunodeficiency are increasing onychomycosis cases. Advanced therapies, such as oral antifungals, topical solutions, and laser treatments, are improving patient outcomes. This is driving market growth. Patients favor minimally invasive and non-systemic treatments. They seek effective solutions with fewer side effects.
New trends are emerging, including innovative drug delivery systems like nail lacquers and new methods for drug penetration. These advances boost treatment effectiveness and improve patient compliance. Combination therapies that merge different treatment methods are also gaining popularity, providing better results for stubborn infections. Additionally, the rise of telemedicine and digital healthcare makes dermatological consultations easier, especially for those in remote areas. As onychomycosis cases rise and new treatments emerge, the U.S. market is poised for continued growth in the coming years.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-onychomycosis-treatment-market/requestsample
United States Onychomycosis Treatment Industry Segmentation:
The report has segmented the market into the following categories:
Disease Type Insights:
Distal Subungual Onychomycosis
Proximal Subungual Onychomycosis
White Superficial Onychomycosis
Candidal Onychomycosis
Others
Treatment Type Insights:
Laser Therapy
Photodynamic Therapy
Drug Treatment
Drug Class Insights:
Allylamine
Azole
Griseofulvin
Others
Distribution Channel Insights:
Hospitals and Clinics
Online Stores
Retail Pharmacies
Others
Regional Insights:
Northeast
Midwest
South
West
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key highlights of the Report:
Market Performance (2019–2024)
Market Outlook (2025–2033)
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Strategic Recommendations
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145